Cargando…
miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
Despite the established benefits of long‐term endocrine therapy, women with hormone receptor‐positive breast cancer remain at risk for late relapse. The basis of this is multi‐factorial including genetic, epigenetic, and host factors. In this study we have explored the epigenetic regulation of estro...
Autores principales: | Nair, Madhumathy G, Prabhu, Jyothi S, Korlimarla, Aruna, Rajarajan, Savitha, P S, Hari, Kaul, Roma, Alexander, Annie, Raghavan, Rohini, B S, Srinath, T S, Sridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402845/ https://www.ncbi.nlm.nih.gov/pubmed/32543775 http://dx.doi.org/10.1002/cam4.3183 |
Ejemplares similares
-
Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes
por: Rajarajan, Savitha, et al.
Publicado: (2021) -
High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers
por: Desai, Krisha, et al.
Publicado: (2016) -
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease
por: Prabhu, Jyothi S, et al.
Publicado: (2017) -
miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling
por: Nair, Madhumathy G., et al.
Publicado: (2022) -
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
por: Prabhu, Jyothi S., et al.
Publicado: (2014)